Pediatric respiratory medicine
- 4 March 2021
- journal article
- research article
- Published by Taylor & Francis in Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
- Vol. 5 (2) , 104-107
Abstract
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also called COVID-19, at the end of 2019 has been the most impactful public health crisis of our time. As of December ...Keywords
This publication has 23 references indexed in Scilit:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and AdolescentsJAMA Pediatrics, 2020
- Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trialsJournal of Cystic Fibrosis, 2020
- Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma ReductionNew England Journal of Medicine, 2020
- The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic FibrosisAnnals of the American Thoracic Society, 2020
- The future of cystic fibrosis care: a global perspectiveThe Lancet Respiratory Medicine, 2020
- Do current clinical trials in cystic fibrosis match the priorities of patients and clinicans? A systematic reviewJournal of Cystic Fibrosis, 2020
- Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotypeJournal of Allergy and Clinical Immunology, 2019
- Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthmaPediatric Pulmonology, 2019
- Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 YearsJAMA, 2016